Wenping Wang

发表

Examining Outlying Subjects and Outlying Records in Bioequivalence Trials

Wenping Wang, Shein-Chung Chow, S. Chow, 2003, Journal of Biopharmaceutical Statistics.

Model-based development of gemcabene, a new lipid-altering agent

M. Milad, J. Mandema, D. Hermann, 2005, The AAPS Journal.

Use of Modeling and Simulation to Optimize Dose-Finding Strategies

J. Mandema, Jaap Mandema, Wenping Wang, 2002 .

Dynamic tumor modeling of the dose–response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

R. Motzer, N. Hollaender, A. Stein, 2012, BMC Cancer.

The Formulation of the Principle of Superposition in the Presence of Non-Compliance and Its Applications in Multiple Dose Pharmacokinetics

S. P. Ouyang, Wenping Wang, 1998, Journal of Pharmacokinetics and Biopharmaceutics.